CCL2 and diabetic kidney disease: In the present study, the significantly higher IL-6, MCP-1, and NF-κB levels in the research group than in the observation group suggest the involvement of IL-6, MCP-1, and NF-κB in the progression of diabetic nephropathy, which was consistent with the results of the previous research [18–21].